Hubungan Kepemimpinan Kepala Ruangan Menurut Persepsi Perawat Terhadap Motivasi Kerja Perawat Pelaksana Di Ruang Instalasi Rawat Inap F Blu Rsup Prof. Dr. R.d. Kandou Manado

: Leadership is the ability to provide a constructive influence others to do the business of the cooperative achieve the planned objectives. Motivation to work an employee is usually indicated by a continuous activity, and goal oriented. The purpose of this study is on the analysis of the relationship to the head of the room under the leadership of the nurse\u27s perception of the motivation of nurses in the inpatient department Prof.Dr.R.D. Kandou F BLU Manado. Analytic survey research design using a cross-sectional approach. Popolasi that all nurses in the inpatient space F BLU Prof. Dr. R.D. Kandou Manado. Total sampling using sampling. Data processed through univariate and bivariate analysis using Chi square with Fisher\u27s exact test alternatives. Results obtained by analysis of the probability (p) = 0.003 <α (0.05), which means that Ho is rejected. Conclusion, an association under the leadership of head room nurse perceptions of the work motivation of nurses in the inpatient department Prof.Dr.RDKandou F BLU Manado. Suggestions, for a head irina F would increase the motivation to work more room nurses, and for nurses would be to maintain and further enhance the motivation to work better

Progression to trachomatous trichiasis.

<p>Progression to trachomatous trichiasis.</p

Natural history of trachoma: Normal healthy tarsal conjunctiva without inflammation, follicular trachoma (TF), intense inflammatory trachoma (TI), scarring trachoma (TS), trichiasis (TT) and corneal opacification (CO).

<p>Ct: <i>Chlamydia trachomatis</i>.</p

Progression from active to scarring trachoma.

<p>Progression from active to scarring trachoma.</p

Progression to corneal opacification, visual impairment and blindness.

<p>Progression to corneal opacification, visual impairment and blindness.</p

Progression of trachomatous trichiasis.

<p>Progression of trachomatous trichiasis.</p

Progression of scarring trachoma.

<p>Progression of scarring trachoma.</p

The relationship between the individual level presence of Active Trachoma (TF or TF/TI) and the detection of <i>C</i>. <i>trachomatis</i> infection by community TF prevalence before the introduction of MDA.

<p>(a) Sensitivity of TF for infection. (b) Specificity of TF for infection. (c) Positive Predictive Value (PPV) of TF for <i>C</i>. <i>trachomatis</i> infection. (d) Negative Predictive Value (NPV) of TF for <i>C</i>. <i>trachomatis</i> infection. Data from population-based studies, summarised in <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005080#pntd.0005080.t001" target="_blank">Table 1</a>. The size of the circles reflects the sample size. Line fitted by linear regression, weighted by the size of the studies, except for the PPV which was fitted by polynomial.</p

The Relationship between Active Trachoma and Ocular <i>Chlamydia trachomatis</i> Infection before and after Mass Antibiotic Treatment - Fig 5

<p>Sensitivity versus specificity of each study, using TF to diagnose <i>C</i>. <i>trachomatis</i> infection at the individual level (a) before and (b) after the introduction of MDA. Each circle represents the estimate for a single study, with the size of the circle representing the size of the study. The red square is the estimated pooled sensitivity and specificity for all studies (Pre- or Post-MDA). The orange dashed line represents the 95% CI (or confidence region in 2 dimensions) for the sensitivity and specificity. The grey curve (hierarchical summary receiver operating characteristic (HSROC) curve) represents the estimated relationship between sensitivity and specificity in these studies, with the grey dashed line indicating the region in which we would expect 95% of studies to fall.</p

The relationship between the prevalence of disease signs and infection before and after the introduction of MDA.

<p>(a) Community prevalence of TF (or TF/TI) vs. the community prevalence of <i>C</i>. <i>trachomatis</i> infection before the introduction of MDA. (b) Community prevalence of TI vs. the community prevalence of <i>C</i>. <i>trachomatis</i> infection before the introduction of MDA. (c) Community prevalence of TF (or TF/TI) vs. the community prevalence of <i>C</i>. <i>trachomatis</i> infection after the introduction of MDA. (d) Community prevalence of TI vs. the community prevalence of <i>C</i>. <i>trachomatis</i> infection after the introduction of MDA. (e) Community prevalence of TF (or TF/TI) vs. the community prevalence of <i>C</i>. <i>trachomatis</i> infection after the introduction of MDA, showing only the communities with less than 15% TF. Data from population-based studies, summarised in Tables <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005080#pntd.0005080.t001" target="_blank">1</a> and <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005080#pntd.0005080.t002" target="_blank">2</a>. The size of the circles reflects the sample size. Line fitted by linear regression, weighted by the size of the studies.</p